Zhejiang Kangle Pharmaceutical

Zhejiang Kangle Pharmaceutical is a Chinese pharmaceutical manufacturer focused on active pharmaceutical ingredients and finished-dose generic medicines. The company traces its origins to Wenzhou Pharmaceutical Factory in 1945 and now operates as Zhejiang Kangle Pharmaceutical Co., Ltd./浙江康乐药业股份有限公司 in Wenzhou, Zhejiang. Its portfolio includes APIs such as acetaminophen, erdosteine, famotidine, cefpodoxime proxetil, netilmicin sulfate, hesperidin, silymarin, glucosamine hydrochloride, and DL-homocysteine thiolactone hydrochloride, alongside commercial dosage forms including tablets, capsules, injections, granules, and infusion products. The business appears to be oriented toward commercial manufacturing rather than novel R&D, with numerous NMPA approvals and no evident clinical-stage proprietary pipeline. The company also has manufacturing subsidiaries and export activity, particularly in APIs and selected finished products.